Close

Not a member yet? Register now and get started.

lock and key

Sign in to your account.

Account Login

Forgot your password?

Equipment & Services  // Browsing posts in Equipment & Services

Nevro’s Senza Offers Unique Treatment Option; Adoption and Sales Will Be Steady (NVRO)

Research Question: Is Nevro’s Senza spinal cord stimulation system the best nondrug chronic pain solution? Companies: ABT, BSX, MDT, NVRO, NVTR By: David Franklin Click here to download report (.pdf)   Summary of Findings Nevro Corp.’s (NVRO) Senza system is providing physicians and patients with chronic lower back and leg pain with a unique HF10 […]

Read more...

Steady Growth Trend Continues for the Dental Market (XRAY)

Research Question: What are the current dental industry market conditions? Companies: ALGN, HSIC, PDCO, WEB, XRAY By: David Franklin Click here to download report (.pdf)   Summary of Findings In a follow-up to Blueshift Research’s 15 report on Dentsply Sirona Inc. (XRAY), dental market conditions continue to fluctuate, but they have improved for all five […]

Read more...

Steady Adoption Growth Expected for Dentsply Sirona’s CEREC (XRAY)

Research Question: Will Dentsply Sirona’s merger lead to accelerated adoption of its CEREC CAD/CAM system? Companies: ALGN, HPE, HSIC, MMM, PDCO, XRAY By: David Franklin Click here to download report (.pdf)   Summary of Findings Dentsply Sirona Inc. (XRAY) will see steady growth in the adoption of its CEREC system, according to 14 of 18 dentists, […]

Read more...

Teleflex’s Premium Pricing Strategy Will Prevail Despite Challenges

Research Question: Will hospitals continue to accept price hikes for Teleflex’s vascular products when competitors are dropping prices? Companies: ABMD, ANGO, BCR, BDX, BSX, CAH, CFN, EW, JNJ, KRX:005935, MDT, MMSI, STJ, TFX, TYO:4543 By: David Franklin Click here to download the report (.pdf)   Summary of Findings Teleflex ’s (TFX) strategy of premium pricing […]

Read more...

Early Warning for ZLTQ’s CoolSculpting: CYNO’s SculpSure Could Cut into Next Year’s Share

Research Question: Can Zeltiq’s CoolSculpting system continue to fend off competitors with similar or superior body contouring products? Companies: AGN, CUTR, CYNO, ELOS, LMNS, NUS, TSE:VRX, ZLTQ By: David Franklin Click here to download the report (.pdf)   Summary of Findings Zeltiq Aesthetics Inc.’s (ZLTQ) CoolSculpting now faces competition from Cynosure Inc.’s (CYNO) recently approved SculpSure […]

Read more...

Novadaq’s SPY Elite: A Solid Technology Facing Moderate Growth Due to Adoption Challenges

Research Question: Will Novadaq’s SPY Elite be widely adopted and drive company growth in 2016? Companies: EPA:MKEA, ETR:SIE, ISRG, NVDQ, TYO:6965 By: David Franklin Click here to download the report (.pdf)   Summary of Findings The medical community considers Novadaq Technologies Inc. (NVDQ) to have innovative and interesting tissue perfusion assessment technology in its product line. […]

Read more...

Abiomed’s Impella Will Drive Growth But Not at Projected 40%

Research Question: Will the Impella propel Abiomed to achieve its 40% growth projections? Companies: ABMD, STJ By: David Franklin Click here to download the report (.pdf)   Summary of Findings The Impella Platform is expected to drive growth for Abiomed Inc. (ABMD) but not at corporate’s 2020 projected sales rate of $1.2 billion to $1.8 billion, […]

Read more...

Exact Sciences’ Cologuard the Preferred Test for Patients Refusing Colonoscopy (EXAS)

Research Question: Will Exact Sciences’ Cologuard become physician’s screening test of choice for colon cancer? Companies: ABT, BDX, BIOC, BSX, CHEK, CPHD, DGX, EXAS, FMI, GIVN, GSK, IRWD, RHHBY By: David Franklin Click here to download the report (.pdf)   Summary of Findings Exact Sciences Corp.’s (EXAS) Cologuard has high clinical value, but it is unlikely […]

Read more...

Zeltiq’s CoolSculpting System and Treatment Sales Expected to Grow

Research Question: Will Zeltiq continue growing system sales and increasing procedure volume for its CoolSculpting system, or is it a fad? Companies: CUTR, ELOS, LMNS, VRX, ZLTQ By: David Franklin Click here to download the report (.pdf)   Summary of Findings Zeltiq Aesthetics Inc.’s (ZLTQ) CoolSculpting procedure is considered the industry-leading noninvasive fat reduction system. CoolSculpting system […]

Read more...

FDA Approval Gives Spectranetics a Window for Moderate Sales Growth

Research Question: Will Spectranetics’ laser atherectomy and PTA become the new standard of treatment for femoropopliteal ISR and be the catalyst for a significant revenue boost? Companies: ABT, BCR, COV, JNJ, SPNC, VOLC By: David Franklin Click here to download the report (.pdf)   Summary of Findings Spectranetics Corp. (SPNC) can expect a moderate sales increase as […]

Read more...